1. Cappella Announces Initiation of Sideguard 3 Study

    vember 16, 2009—Cappella, Inc. (Galway, Ireland) announced commencement of Sideguard 3, an intravascular ultrasound/optical coherence tomography evaluation of the company's Sideguard coronary sidebranch stent and delivery system. This is a European multicenter study to evaluate the vascular response to Sideguard in de novo bifurcation lesions of native coronary arteries. The primary objective of the study is to determine the change in stent area (mm²) and corresponding change in vessel area (mm²) at the carina of the sidebranch during the 6-month follow-up period. Gary S. Mintz, MD, and Akiko Maehara, MD, of the Cardiovascular Research Foundation in New ...
    Read Full Article

    Login to comment.

  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Topics Mentioned